Chemical industry in China

projects tracked
97
active
48

Projects in China

chemXplore tracks 97 projects in China, of which 48 are active.

  1. 18 projects Announced / Concept
  2. 1 project FEED / Pre-FID
  3. 2 projects FID / Sanctioned
  4. 22 projects Under Construction
  5. 5 projects Commissioning & Start-up

Of the active ones, 32 new construction, 13 expansion and 3 revamp / retrofit.

Expected start-up, by year
0 2 4 6 8 2026 2027 2028 2029 2030 2031

26 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.

What moved recently

  • 27 October 2026 Sinopec Carbon Technology Jiangsu Provincial Industrial Virtual Power Plant · Operational / Completed
  • 27 October 2026 Stora Enso and Shanshan Ningbo lignin-based hard carbon demo line · Announced / Concept
  • 16 October 2026 Sinopec Shengli Oilfield Million-Tonne Low-Concentration Flue-Gas CCUS Demonstration · Under Construction
  • 15 October 2026 PetroChina Tarim 1.2 Mt/yr phase II ethylene project · Operational / Completed
  • 15 October 2026 Arkema Shanghai R&D Center Laboratory Expansion · Operational / Completed

Latest Chinese chemical industry news

16 November 2026
Sinopec ships first pyrolysis-oil-based recycled benzene from Cangzhou

The shipment marks a production-and-sales loop for products made by processing pyrolysis oil in existing refining and chemical units.

13 November 2026
Sinopec strengthens gas supply and geothermal heating for winter

Plans include 56 new wells, full storage at 13 gas-storage sites and geothermal heating capacity of 146 million m².

12 November 2026
Sinopec adapts its station network to the electric-vehicle shift

Charging, battery swapping, hydrogen, energy storage and digital power trading are reshaping station operations.

12 November 2026
Sinopec develops embodied-intelligence pressure-gauge calibration device

The system calibrates four gauges in 5–6 minutes and achieves up to 99.7% reading recognition.

12 November 2026
CNPC Shanghai forum focuses on energy security and CIIE procurement

The event convened more than 200 guests and included agreements worth over $18.8 billion across oil and gas, equipment and low-carbon development.

10 November 2026
Bayer’s asundexian (Sunharbo) FDA-approved as first FXIa inhibitor for secondary stroke prevention

Oral once-daily 50 mg FXIa inhibitor, given with antiplatelet therapy, cut ischemic stroke risk by 26% versus antiplatelets alone in a 12,327‑patient Phase III trial with similar major bleeding rates.

9 November 2026
SOCAR and Sinopec Corp. sign strategic cooperation MoU

Agreement to cooperate on procurement and supply chain management, including supplier information exchange, best-practice sharing, and exploring integration of products, equipment and services.

9 November 2026
Genentech and Roche present trontinemab, RG6434 and Elecsys pTau data at CTAD 2026

PrevenTRON Phase III enrollment has started; Phase II TARBELA-AD launched for oral NLRP3 inhibitor RG6434; Brainshuttle trontinemab shows rapid amyloid removal; new Elecsys pTau217/pTau181 data published.

9 November 2026
Nippon Shokubai FY2026 Financial Results

Quarterly revenue and profits rose; full-year forecasts upgraded; new 50,000 t/yr SAP plant set for July 2027; shareholder returns include a ¥6bn buyback and higher dividend.

7 November 2026
argenx: Phase 3 ALKIVIA shows efgartigimod delivers rapid, sustained benefit in autoimmune myositis

Phase 3 ALKIVIA met primary and key secondary endpoints in combined IMNM and DM; argenx will file an sBLA for IMNM by end‑2026 following Breakthrough Therapy designation.